A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma

Hsu F.-S.Su C.-H.KUO-HOW HUANG2021-01-282021-01-2820172314-8861https://www.scopus.com/inward/record.uri?eid=2-s2.0-85042470392&doi=10.1155%2f2017%2f6940546&partnerID=40&md5=112f65ae6aeca70aad47154a712d4c04https://scholars.lib.ntu.edu.tw/handle/123456789/543637A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinomareview10.1155/2017/6940546293760812-s2.0-85042470392